Abstract
Ceftriaxone and linezolid are commonly used antibiotics in infective endocarditis. Here we present a rare case of severe anemia caused by both the drugs via different mechanisms. Drugs have shown significant contribution in inducing anemia via hemolysis and bone marrow suppression in an infective endocarditis patient.
Keywords: Anemia, blood pressure, ceftriaxone, endocarditis, platelet.
Graphical Abstract
Cardiovascular & Hematological Disorders-Drug Targets
Title:Multiple Drugs Causing Severe Anemia in Infective Endocarditis
Volume: 16 Issue: 1
Author(s): Ajit Singh, Prasad N. Shetty, Brij Mohan Kumar Singh and Tom Devasia
Affiliation:
Keywords: Anemia, blood pressure, ceftriaxone, endocarditis, platelet.
Abstract: Ceftriaxone and linezolid are commonly used antibiotics in infective endocarditis. Here we present a rare case of severe anemia caused by both the drugs via different mechanisms. Drugs have shown significant contribution in inducing anemia via hemolysis and bone marrow suppression in an infective endocarditis patient.
Export Options
About this article
Cite this article as:
Singh Ajit, Shetty N. Prasad, Singh Mohan Kumar Brij and Devasia Tom, Multiple Drugs Causing Severe Anemia in Infective Endocarditis, Cardiovascular & Hematological Disorders-Drug Targets 2016; 16 (1) . https://dx.doi.org/10.2174/1871529X16666160524144527
DOI https://dx.doi.org/10.2174/1871529X16666160524144527 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Potential Application of Antimicrobial Peptides in the Treatment of Bacterial Biofilm Infections
Current Pharmaceutical Design Probiotics in Intestinal and Non-Intestinal Infectious Diseases – Clinical Evidence
Current Pharmaceutical Design Vaccines and Photodynamic Therapies for Oral Microbial-Related Diseases
Current Drug Metabolism Editorial [Hot topic: Infective Endocarditis (Guest Editor: Ioannis Starakis)]
Cardiovascular & Hematological Disorders-Drug Targets Secondary Stroke Prevention in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Vascular Disease Prevention (Discontinued) Plasma Pharmacokinetics of Antimicrobial Agents in Critically Ill Patients
Current Clinical Pharmacology Pneumonia Due to Methicilin-Resistant Staphylococcus aureus (MRSA): A Review
Current Respiratory Medicine Reviews Molecular Dynamics Simulations of Novel Potential Inhibitors for Penicillin Binding Protein 2B of the Resistant 5204 Strain of Streptococcus pneumoniae
Current Computer-Aided Drug Design Heart Failure in South America
Current Cardiology Reviews Recent Developments in Antithrombotic Therapy: Will Sodium Warfarin Be a Drug of the Past?
Recent Patents on Cardiovascular Drug Discovery Pulmonary Complications After Congenital Heart Surgery
Current Respiratory Medicine Reviews Ethanol and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Strategies for Antimicrobial Drug Delivery to Biofilm
Current Pharmaceutical Design Current Status of Molecular Imaging in Infections
Current Pharmaceutical Design Riboswitches as Potential Targets for the Development of Anti-Biofilm Drugs
Current Topics in Medicinal Chemistry New Developments in Antimicrobial Use in Sepsis
Current Pharmaceutical Design The Gut Mucosa as a Site for Induction of Regulatory T-Cells
Current Pharmaceutical Design Biosynthesis and Genetic Engineering of Lipopeptide Antibiotics Related to Daptomycin
Current Topics in Medicinal Chemistry Update on Childhood Brucellosis
Recent Patents on Anti-Infective Drug Discovery